Michael Atkins

May 6, 2024 | nature.com | Homaira Hamidzada |Uros Kuzmanov |Renee Gorman |Michael Atkins |Babak Razani |Ana Andreazza | +2 more

AbstractYolk sac macrophages are the first to seed the developing heart; however, owing to a lack of accessible tissue, there is no understanding of their roles in human heart development and function. In this study, we bridge this gap by differentiating human embryonic stem (hES) cells into primitive LYVE1+ macrophages (hESC-macrophages) that stably engraft within contractile cardiac microtissues composed of hESC-cardiomyocytes and fibroblasts.

Jan 3, 2024 | targetedonc.com | Michael Atkins

January 3, 2024Michael B Atkins, MD, shares insights on the prognosis of patient’s diagnosed with advanced melanoma and discusses the value of BRAF mutation testing. Case: A 62-Year-Old Female with Stage IV MelanomaA 62-year-old female consulted with her dermatologist for removal of a pigmented lesion that had recently become darker. She noted that she had been experiencing persistent fatigue, shortness of breath, and a dry cough that she attributed to a prior COVID-19 infection.

Dec 19, 2023 | targetedonc.com | Michael Atkins

December 19, 2023Michael B. Atkins, MD, reviews a case involving a female patient who was diagnosed with stage IV BRAF-mutated melanoma, and shares insights on the patient’s prognosis and his approach to diagnosis. Case: A 62-Year-Old Female with Stage IV MelanomaA 62-year-old female consulted with her dermatologist for removal of a pigmented lesion that had recently become darker.

Jun 30, 2023 | urotoday.com | Michael Atkins

Read the Full Video TranscriptPedro Barata: Hi there and welcome. I'm Pedro Barata. I'm a GU medical oncologist at Seidman Cancer Center, Case Western University in Cleveland, Ohio. It's my privilege to welcome Dr. Michael Atkins. Dr. Atkins is obviously known from everybody in the kidney cancer world and beyond, melanoma and beyond.

Feb 22, 2023 | urotoday.com | Michael Atkins

Read the Full Video TranscriptPedro Barata: Hi, I'm Pedro Barata. I'm a GU medical oncologist and a director of the clinical research program for Advanced GU Tumors at University Hospital Seidman Cancer Center in Cleveland. I'm very, very happy to be joined by Dr. Michael Atkins. Dr. Atkins is a giant in the field of GU. He's also the deputy director of the Georgetown Lombardi Comprehensive Cancer Center in Washington, DC. Dr. Atkins, welcome. Thank you for joining us today.